Hokkaido University Innovates Blood Triglyceride Detection with Light

Hokkaido University Innovates Blood Triglyceride Detection with Light

2025-06-13 photonics

Sapporo, Friday, 13 June 2025.
Hokkaido University has developed a device that measures blood triglycerides without a blood sample using near-infrared light, potentially improving comfort and cardiovascular health management.

Revolutionizing Health Monitoring with Photonics

Medical Photonics, a company based in Sapporo, Japan, has introduced a cutting-edge device that leverages photonics to provide non-invasive blood triglyceride measurement. This device illuminates the arm with near-infrared light, which penetrates the skin and generates data for triglyceride assessment by analyzing the exiting light [1]. Developed from the research led by Professor Kaiichi Iinaga, this innovation promises a significant reduction in patient discomfort and a streamlined process for lipid monitoring [1].

Significance for Cardiovascular Health

Monitoring blood triglyceride levels is crucial for preventing severe health conditions such as strokes and heart attacks. Elevated triglycerides are a risk factor for these conditions, and regular monitoring can play a critical role in managing cardiovascular health [1]. By eliminating the need for traditional blood draws, this device offers a more patient-friendly alternative, potentially encouraging more consistent monitoring among patients.

Technology Mechanics and Implications

The innovation utilizes the body’s interaction with light, a principle known as biophotonics. By measuring the scattering and absorption coefficients as the near-infrared light passes through the tissues, the device can accurately determine triglyceride levels [1]. This non-invasive technology not only simplifies the process for patients but also holds promise for other applications in medical diagnostics.

The Future of Non-Invasive Monitoring

As Medical Photonics begins testing its device with healthcare researchers and food companies later this year, the potential for widespread adoption could reshape patient care practices [1]. By providing a reliable alternative to traditional blood tests, this technology could redefine standard procedures and significantly enhance patient compliance and overall health outcomes.

Bronnen


photonics technology medical innovation